Q fever

被引:541
作者
Angelakis, Emmanouil [1 ]
Raoult, Didier [1 ]
机构
[1] Univ Mediterranee, CNRS, UMR 6020, Unite Rickettsies,IFR 48, F-13385 Marseille 05, France
关键词
Q fever; Coxiella burnetii; COXIELLA-BURNETII INFECTION; REAL-TIME PCR; SHELL-VIAL ASSAY; ANTIBIOTIC SUSCEPTIBILITY; MONOCLONAL-ANTIBODIES; FOLLOW-UP; BACTERIAL PHAGOCYTOSIS; ACTIN CYTOSKELETON; RESISTANT STRAIN; UNITED-STATES;
D O I
10.1016/j.vetmic.2009.07.016
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Q fever is a zoonotic disease caused by the ubiquitous pathogen Coxiella burnetii responsible for acute and chronic clinical manifestations. Farm animals and pets are the main reservoirs of infection, and transmission to human beings is mainly accomplished through inhalation of contaminated aerosols. This illness is associated with a wide clinical spectrum, from asymptomatic or mildly symptomatic seroconversion to fatal disease. In humans Q fever can manifest as an acute disease (mainly as a self-limited febrile illness, pneumonia, or hepatitis) or as a chronic disease (mainly endocarditis), especially in patients with previous valvulopathy and to a lesser extent in immunocompromised hosts and in pregnant women. In contrast in animals, Q fever is in most cases, strikingly asymptomatic. The definite diagnosis of Q fever is made based on a significant increase in serum antibody titers, the determination of which often requires considerable time, and therefore patients must be monitored for a certain period. The treatment is effective and well tolerated, but must be adapted to the acute or chronic pattern with the tetracyclines to be considered the mainstay of antibiotic therapy. Several actions have been proposed to prevent and reduce the animal and environmental contamination. Vaccination of animals in infected flocks, as well as in uninfected ones close to them, with an efficient vaccine can prevent abortions and shedding of the bacteria. (C) 2009 Elsevier B.V. All rights reserved
引用
收藏
页码:297 / 309
页数:13
相关论文
共 126 条
[41]   CYNOMOLGUS MONKEY MODEL FOR EXPERIMENTAL Q-FEVER INFECTION [J].
GONDER, JC ;
KISHIMOTO, RA ;
KASTELLO, MD ;
PEDERSEN, CE ;
LARSON, EW .
JOURNAL OF INFECTIOUS DISEASES, 1979, 139 (02) :191-196
[42]   BIOCHEMICAL STRATAGEM FOR OBLIGATE PARASITISM OF EUKARYOTIC CELLS BY COXIELLA-BURNETII [J].
HACKSTADT, T ;
WILLIAMS, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (05) :3240-3244
[43]  
HARMAN JB, 1949, LANCET, V257, P1028
[44]  
Hatchette T, 2000, Can Commun Dis Rep, V26, P17
[45]   Changing epidemiology of Q fever in Germany, 1947-1999 [J].
Hellenbrand, W ;
Breuer, T ;
Petersen, L .
EMERGING INFECTIOUS DISEASES, 2001, 7 (05) :789-796
[46]   Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through toll-like receptor 4 [J].
Honstettre, A ;
Ghigo, E ;
Moynault, A ;
Capo, C ;
Toman, R ;
Akira, S ;
Takeuchi, O ;
Lepidi, H ;
Raoult, D ;
Mege, JL .
JOURNAL OF IMMUNOLOGY, 2004, 172 (06) :3695-3703
[47]   A COXIELLA-BURNETII REPEATED DNA ELEMENT RESEMBLING A BACTERIAL INSERTION-SEQUENCE [J].
HOOVER, TA ;
VODKIN, MH ;
WILLIAMS, JC .
JOURNAL OF BACTERIOLOGY, 1992, 174 (17) :5540-5548
[48]   Phase variation analysis of Coxiella burnetii during serial passage in cell culture by use of monoclonal antibodies [J].
Hotta, A ;
Kawamura, M ;
To, H ;
Andoh, M ;
Yamaguchi, T ;
Fukushi, H ;
Hirai, K .
INFECTION AND IMMUNITY, 2002, 70 (08) :4747-4749
[49]   Changing clinical presentation of Q fever endocarditis [J].
Houpikian, P ;
Habib, G ;
Mesana, T ;
Raoult, D .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (05) :E28-E31
[50]   Q-FEVER STUDIES IN SOUTHERN CALIFORNIA - SUMMARY OF CURRENT RESULTS AND A DISCUSSION OF POSSIBLE CONTROL MEASURES [J].
HUEBNER, RJ ;
BELL, JA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1951, 145 (05) :301-305